ProQR (PRQR) CEO Daniel de Boer Buys 200,000 Shares

What Happened Daniel Anton de Boer, CEO of ProQR Therapeutics N.V. (PRQR), reported an open-market purchase of 200,000 ordinary shares on July 31, 2026. The shares were acquired at $1.77 per share for a total transaction value of approximately $353,960. This was a direct purchase (transaction code P).

Key Details

• Transaction date: July 31, 2026; Filing date: August 3, 2026 (filed within the two-business-day Form 4 reporting window).
• Price: $1.77 per share; Shares acquired: 200,000; Total value: ~$353,960.
• Transaction type: Open-market purchase (P = Purchase).
• Shares owned after transaction: Not specified in the provided summary—see the full Form 4 (Accession 0001104659-26-089780) for total holdings and any footnotes.
• Notable footnotes/flags: None provided here. Check the Form 4 for any 10b5‑1 plan, tax withholding, or other notes.

Context Open-market purchases by executives are direct acquisitions of company stock and can be informative to investors; they are factual disclosures and do not prove intent. For full ownership details or any special instructions (e.g., 10b5‑1 trading plan), review the complete SEC Form 4 filing.